Plasmodium falciparum CyRPA Glycan Binding Does Not Explain Adaptation to Humans.

Area of Science:

• Evolutionary biology
• Parasitology
• Glycobiology

Background:

• The human malaria parasite, Plasmodium falciparum, is believed to have evolved from a gorilla-infecting ancestor, Plasmodium praefalciparum.
• Differences in erythrocyte surface sialic acids exist between humans and apes, influencing parasite binding.
• Plasmodium falciparum cysteine-rich protective antigen (PfCyRPA) binds human sialoglycans for erythrocyte invasion.

Purpose of the Study:

• To investigate the evolutionary adaptation of Plasmodium falciparum to human hosts.
• To determine the role of specific amino acid changes in PfCyRPA in glycan binding specificity.

Main Methods:

• Comparative analysis of PfCyRPA protein sequences between Plasmodium falciparum and Plasmodium praefalciparum.
• Examination of amino acid residues within and near the glycan binding sites of PfCyRPA.

Main Results:

• Amino acid sites 154 and 209 in PfCyRPA are identical between P. falciparum and P. praefalciparum.
• These key sites, previously thought to confer human-specific binding, show no differences.
• No other significant differences were found in or near the PfCyRPA glycan binding sites between the two parasites.

Conclusions:

• The ancestral gorilla parasite, P. praefalciparum, likely possessed pre-existing adaptations for binding human sialoglycans.
• The evolution of P. falciparum to humans may not solely depend on the identified amino acid changes in PfCyRPA.
• This suggests a more complex evolutionary pathway for malaria parasite adaptation to new hosts.